http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007147429-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-22 |
| filingDate | 2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007147429-A |
| titleOfInvention | ORGANIC COMPOUNDS |
| abstract | 1. The compound of formula (I)! ! in free form or in the form of a pharmaceutically acceptable salt in which! Q is selected from -C (O) OR6 and -C (O) N7R8,! R1 is selected from OH, R1aS-, R1aO- and R1aNR9-, where R1a is where R1b and R1c are independently hydrogen, (C1-C8) alkyl or together with the carbon atom to which they are attached form a divalent (C3 -C8) cycloaliphatic group! R2 and R3 are independently hydrogen, (C1-C8) alkyl, or together with the carbon atom to which they are attached form a divalent (C3-C8) cycloaliphatic group,! R4 and R5 are independently halogen, (C1-C8) alkyl, halogen (C1-C8) alkyl, (C3-C15) carbocyclic group, nitro group, cyano group, (C1-C8) alkylthionyl group, (C1-C8) alkylsulfonyl group, halogen (C1-C8) alkylsulfonyl group, (C1-C8) alkylcarbonyl group, (C1-C8) alkoxycarbonyl group, (C1-C8) alkoxy group, halogen (C1-C8) alkoxy group, carboxy group, carboxy (C1 ) alkyl, amino group, (C1-C8) alkylamino group, di [(C1-C8) alkyl] amino group, SO2NH2, [(C1-C8) alkylamino] sulfonyl group, di [(C1-C8) alkyl] aminosulfonyl a group, an aminocarbonyl group, a (C1-C8) alkylaminocarbonyl group, a di [(C1-C8) alkyl] aminocarbonyl group, or a heterocyclic group containing from 4 to 10 atoms and including one or more heteroatoms selected from the group consisting of oxygen, nitrogen and sulfur! R6 is selected from hydrogen, (C1-C8) alkyl, (C3-C5) cycloalkyl, (C1-C8) alkyl [(C6-C15) aromatic carbocyclic group] and (C6-C15) aromatic carbocyclic group,! R7 is hydrogen or (C1-C8) alkyl,! R8 is (C3-C15) cycloalkyl,! R9 and R10 are independently selected from hydrogen, ( |
| priorityDate | 2005-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.